We all know that Alfred Bernhard Nobel made his millions with the
discovery of nitroglycerine a component of dynamite, and other explosive
substances. In 1895 he developed a condition called angina pectoris and died of
cerebral haemorrhage in 1896. When blood vessels which supply blood to
the chest muscle are constricted, depleted blood supply and the resultant
depletion of oxygen supply cause chest pain known medically as angina pectoris.
The reason for Alfred bequeathing the bulk of his estate for the
endowment of the famous Nobel Prizes is not clear. According to a
theory, when in 1888 his brother Ludvig died in France, a French newspaper mistaking
him to be Alfred reported, “The merchant of death is dead.” (The
expression used in the Indian context was not original, after all!) It was
possible Alfred wanted to make reparation for his probable posthumous notoriety.
In 1944 Antoine Balard working
at the Sorbonne observed that inhalation of isoamyl nitrate gave him headache.
Other researchers like Frederick Guthrie in Owen’s College, Manchester experimented with nitrates.
Thomas Lauder Brunton, a researcher who worked at the Edinburgh Royal Infirmary
put nitroglycerine to use. It was William
Murrell’s work at the Westminster Hospital (his findings were published in The
Lancet) that confirmed nitroglycerine dilates blood vessels,
reduces blood pressure and relieves pain caused by angina pectoris. In the
initial days British doctors took care to see that patients were not unduly
scared if they found out that the tablets they were prescribed were the same
compound that was used in dynamite. The longer acting form of nitroglycerine
(pentaerythritol
tetranitrate)
was introduced in 1896 on an experimental scale and its applicability was
finally announced in 1901. Had it been in use in 1896, it would probably have saved
Alfred Nobel’s life! The active form of the drug known as isosorbide is
prescribed (for sublingual use for faster absorption) even today.
While on the subject of
angina pectoris, the multinational pharmaceutical company Pfizer, which
experimented with sildenafil citrate, was unable to obtain desired
results. It did not reduce cardiac pain as the researchers hoped. However the
researchers were pleasantly surprised by an unintended effect the drug caused.
In some patients it caused penile erections. Enthused by a study conducted in
the Johns
Hopkins University, Pfizer continued work on sildenafil. An enzyme called nitric
oxide synthase (NOS) localised in the penis produces the neurotransmitter nitric
oxide, which is responsible for penile erection. Sildenafil was
found to reverse the action of NOS inhibitors. Thus was borne the blue pill
known the world over as Viagra! What is less known is that Viagra
is equally effective in women, in inducing clitoral erection. It is
particularly useful for women with sexual dysfunction caused by a class of antidepressant
drugs known as selective serotonin reuptake inhibitors (SSRIs).
Another drug minoxidil
which was originally intended to lower blood pressure turned out to have an
unintended consequence. In initial trials it caused body hair growth in some
female patients. Continued trials with the drug proved that it is useful for
hair regrowth in what is known as ‘male pattern baldness’. There are other
drugs with a similar ‘side effect’ but are limited in their use because of other
concomitant adverse effects. The advantage with minoxidil is that it is
available as a lotion and can be locally applied.
What is strange
in the current scenario is for researchers trying to look for anti–viral
properties in every conceivable drug. In the absence of a preventive vaccine
for the COVID–19 virus, researchers have experimented with hydroxychloroquine
an anti–malarial drug, also found to be useful in the treatment of rheumatoid
arthritis, azithromycin an anti–biotic and remdesivir an anti–viral drug—with varying results. As the
pandemic grips the whole world, there is prestige involved in being the first
to find a remedy for it.
The latest candidate drug under experimentation is dexamethasone.
A group of researchers at the University of Oxford said “trial results show the drug [dexamethasone]
reduced death rates of the most severely-ill Covid-19 patients by around a
third.” The British Prime Minister hailed it as the “biggest breakthrough yet”
in the fight against the disease. However, as per a report published in the Independent,
US experts led by Dr. Kathryn Hibbert, director of the intensive care unit at
Harvard’s Massachusetts General Hospital expressed scepticism about the
findings of the trial. They cited the recent publication and withdrawal of a
study in The Lancet, the results of a trial with hydroxychloroquine as a cautionary
tale. (“Dexamethasone: US doctors cast doubton UK’s coronavirus ‘breakthrough’”, June 17, 2020.)
Dexamethasone belongs to a group of drugs called glucocorticoids.
As the name suggests the primary function of glucocorticoids is to
conserve glucose for use in times of stress. The glucocorticoids convert
carbohydrate into glycogen and store it in the liver. But corticosteroids
are also known immunosuppressants. It is for this reason they are prescribed
along with other immunosuppressive drugs like cyclosporine and azathioprine
to prevent donor organ rejection in organ transplant cases. An earlier
commentary article published in The Lancet (“Steroids could do more harm than good in treating coronavirus”, February 6, 2020) highlighted the immunosuppressant property
of the drug and advised caution in including it in treatment regimens for
COVID–19.
As experts
and researchers grapple with finding a remedy for the corona virus infection
that has changed the world forever, the last word on the subject is yet to be
said!
This is a slightly modified version of the article
originally published in The Time Of India Blogs
Labels: Analgesics, Azithromycin, Anti–cancer drugs, Antihistamines, Anti–psychotic
drugs, Corticosteroids, Dexamethasone, Glucocorticoids, Hydroxychloroquine, Isosorbide,
Lidocaine, Minoxidil, Nitroglycerine, Nobel, Penicillin, Post–it, Remdesivir,
Tranquilisers, Serendipity, Sildenafil, Viagra
